
- <Centre d'Information et de documentation du CRA Rhône-Alpes
- CRA
- Informations pratiques
-
Adresse
Centre d'information et de documentation
Horaires
du CRA Rhône-Alpes
Centre Hospitalier le Vinatier
bât 211
95, Bd Pinel
69678 Bron CedexLundi au Vendredi
Contact
9h00-12h00 13h30-16h00Tél: +33(0)4 37 91 54 65
Mail
Fax: +33(0)4 37 91 54 37
-
Adresse
Détail de l'auteur
Auteur Mathijs DEEN |
Documents disponibles écrits par cet auteur (2)



Age at autism spectrum disorder diagnosis: A systematic review and meta-analysis from 2012 to 2019 / Maarten VAN 'T HOF in Autism, 25-4 (May 2021)
![]()
[article]
Titre : Age at autism spectrum disorder diagnosis: A systematic review and meta-analysis from 2012 to 2019 Type de document : Texte imprimé et/ou numérique Auteurs : Maarten VAN 'T HOF, Auteur ; Chanel TISSEUR, Auteur ; Ina VAN BERCKELEAR-ONNES, Auteur ; Annemyn VAN NIEUWENHUYZEN, Auteur ; Amy M. DANIELS, Auteur ; Mathijs DEEN, Auteur ; Hans W HOEK, Auteur ; Wietske A. ESTER, Auteur Article en page(s) : p.862-873 Langues : Anglais (eng) Mots-clés : age at diagnosis autism spectrum disorder influencing factors meta-analysis review Index. décimale : PER Périodiques Résumé : We currently assume that the global mean age at diagnosis of autism spectrum disorder ranges from 38 to 120?months. However, this range is based on studies from 1991 to 2012 and measures have since been introduced to reduce the age at autism spectrum disorder diagnosis. We performed a systematic review and meta-analysis (statistical analysis that combines the results of multiple scientific studies) for studies published between 2012 and 2019 to evaluate the current age at autism spectrum disorder diagnosis. We included 56 studies that reported the age at diagnosis for 40 countries (containing 120,540 individuals with autism spectrum disorder). Results showed the current mean age at diagnosis to be 60.48?months (range: 30.90-234.57?months) and 43.18?months (range: 30.90-74.70?months) for studies that only included children aged ?10?years. Numerous factors that may influence age at diagnosis (e.g. type of autism spectrum disorder diagnosis, additional diagnoses and gender) were reported by 46 studies, often with conflicting or inconclusive results. Our study is the first to determine the global average age at autism spectrum disorder diagnosis from a meta-analysis. Although progress is being made in the earlier detection of autism spectrum disorder, it requires our constant attention. En ligne : http://dx.doi.org/10.1177/1362361320971107 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=444
in Autism > 25-4 (May 2021) . - p.862-873[article] Age at autism spectrum disorder diagnosis: A systematic review and meta-analysis from 2012 to 2019 [Texte imprimé et/ou numérique] / Maarten VAN 'T HOF, Auteur ; Chanel TISSEUR, Auteur ; Ina VAN BERCKELEAR-ONNES, Auteur ; Annemyn VAN NIEUWENHUYZEN, Auteur ; Amy M. DANIELS, Auteur ; Mathijs DEEN, Auteur ; Hans W HOEK, Auteur ; Wietske A. ESTER, Auteur . - p.862-873.
Langues : Anglais (eng)
in Autism > 25-4 (May 2021) . - p.862-873
Mots-clés : age at diagnosis autism spectrum disorder influencing factors meta-analysis review Index. décimale : PER Périodiques Résumé : We currently assume that the global mean age at diagnosis of autism spectrum disorder ranges from 38 to 120?months. However, this range is based on studies from 1991 to 2012 and measures have since been introduced to reduce the age at autism spectrum disorder diagnosis. We performed a systematic review and meta-analysis (statistical analysis that combines the results of multiple scientific studies) for studies published between 2012 and 2019 to evaluate the current age at autism spectrum disorder diagnosis. We included 56 studies that reported the age at diagnosis for 40 countries (containing 120,540 individuals with autism spectrum disorder). Results showed the current mean age at diagnosis to be 60.48?months (range: 30.90-234.57?months) and 43.18?months (range: 30.90-74.70?months) for studies that only included children aged ?10?years. Numerous factors that may influence age at diagnosis (e.g. type of autism spectrum disorder diagnosis, additional diagnoses and gender) were reported by 46 studies, often with conflicting or inconclusive results. Our study is the first to determine the global average age at autism spectrum disorder diagnosis from a meta-analysis. Although progress is being made in the earlier detection of autism spectrum disorder, it requires our constant attention. En ligne : http://dx.doi.org/10.1177/1362361320971107 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=444 First Psychometric Properties of the Dutch Interview for Diagnostic Assessment of Autism Spectrum Disorder in Adult Males Without Intellectual Disability / Richard VUIJK in Journal of Autism and Developmental Disorders, 52-8 (August 2022)
![]()
[article]
Titre : First Psychometric Properties of the Dutch Interview for Diagnostic Assessment of Autism Spectrum Disorder in Adult Males Without Intellectual Disability Type de document : Texte imprimé et/ou numérique Auteurs : Richard VUIJK, Auteur ; Mathijs DEEN, Auteur ; Arnoud ARNTZ, Auteur ; Hilde M. GEURTS, Auteur Article en page(s) : p.3523-3535 Langues : Anglais (eng) Mots-clés : Adolescent Adult Aged Autism Spectrum Disorder/diagnosis/epidemiology Ethnicity Humans Intellectual Disability/diagnosis/epidemiology Male Middle Aged Psychometrics Reproducibility of Results Sensitivity and Specificity Young Adult Autism spectrum disorder (ASD) Interrater agreement Nida Personality disorder (PD) Validity Index. décimale : PER Périodiques Résumé : For autism spectrum disorder (ASD) in adults there are several diagnostic instruments available with a need for consideration of the psychometric properties. This study aimed to conduct a first psychometric evaluation of a new diagnostic ASD instrument, the NIDA (Dutch Interview for Diagnostic assessment of ASD in adults) in 90 adult males without intellectual disability (age 18-65Â years) in the Netherlands: 30 with ASD, 30 with a Personality Disorder and 30 nonpatient controls. The interrater agreement ranged from 0.79 to 1.00, the convergent validity including sensitivity and specificity ranged from 0.76 to 1.00, and we observed an adequate concurrent criterion-related validity. These promising findings can serve as foundation for future psychometric NIDA studies in a more diverse population. TRIAL REGISTRATION: The Netherlands National Trial Register NTR6391. Registered 04 May 2017. En ligne : http://dx.doi.org/10.1007/s10803-021-05225-z Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=485
in Journal of Autism and Developmental Disorders > 52-8 (August 2022) . - p.3523-3535[article] First Psychometric Properties of the Dutch Interview for Diagnostic Assessment of Autism Spectrum Disorder in Adult Males Without Intellectual Disability [Texte imprimé et/ou numérique] / Richard VUIJK, Auteur ; Mathijs DEEN, Auteur ; Arnoud ARNTZ, Auteur ; Hilde M. GEURTS, Auteur . - p.3523-3535.
Langues : Anglais (eng)
in Journal of Autism and Developmental Disorders > 52-8 (August 2022) . - p.3523-3535
Mots-clés : Adolescent Adult Aged Autism Spectrum Disorder/diagnosis/epidemiology Ethnicity Humans Intellectual Disability/diagnosis/epidemiology Male Middle Aged Psychometrics Reproducibility of Results Sensitivity and Specificity Young Adult Autism spectrum disorder (ASD) Interrater agreement Nida Personality disorder (PD) Validity Index. décimale : PER Périodiques Résumé : For autism spectrum disorder (ASD) in adults there are several diagnostic instruments available with a need for consideration of the psychometric properties. This study aimed to conduct a first psychometric evaluation of a new diagnostic ASD instrument, the NIDA (Dutch Interview for Diagnostic assessment of ASD in adults) in 90 adult males without intellectual disability (age 18-65Â years) in the Netherlands: 30 with ASD, 30 with a Personality Disorder and 30 nonpatient controls. The interrater agreement ranged from 0.79 to 1.00, the convergent validity including sensitivity and specificity ranged from 0.76 to 1.00, and we observed an adequate concurrent criterion-related validity. These promising findings can serve as foundation for future psychometric NIDA studies in a more diverse population. TRIAL REGISTRATION: The Netherlands National Trial Register NTR6391. Registered 04 May 2017. En ligne : http://dx.doi.org/10.1007/s10803-021-05225-z Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=485